<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-vaccines-07-00046">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Engineered outer membrane vesicle is potent to elicit HPV16E7-specific cellular immunity in a mouse model of TC-1 graft tumor</article-title>
  <source>Int. J. Nanomed.</source>
  <year>2017</year>
  <volume>12</volume>
  <fpage>6813</fpage>
  <lpage>6825</lpage>
  <pub-id pub-id-type="doi">10.2147/IJN.S143264</pub-id>
 </element-citation>
</ref>
